Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.730
+0.010 (0.58%)
Jan 14, 2026, 4:00 PM EST - Market closed
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $64.96 million as of January 15, 2026. Its market cap has decreased by -53.59% in one year.
Market Cap
64.96M
Enterprise Value
-77.50M
1-Year Change
-53.59%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $64.96M, a decrease of -88.46%. That is a compound annual growth rate of -67.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 64.96M | 6.79% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |